n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kyle, DJ; Lowe, VC; Noronha-Blob, L; Otterbein, L | 1 |
| Burch, RM; Lowe, VC; Noronha-Blob, L; Weitzberg, M | 1 |
2 other study(ies) available for n-(9h-(2,7-dimethylfluoren-9-ylmethoxy)carbonyl)leucine and Shock, Septic
| Article | Year |
|---|---|
Additive effects of a bradykinin antagonist, NPC 17761, and a leumedin, NPC 15669, on survival in animal models of sepsis.
Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents, Non-Steroidal; Bradykinin; Bradykinin Receptor Antagonists; Disease Models, Animal; Drug Synergism; Endotoxins; Leucine; Male; Mice; Molecular Sequence Data; Peritonitis; Rats; Rats, Sprague-Dawley; Shock, Septic; Survival Rate | 1993 |
NPC 15669 enhances survival and reverses leukopenia in endotoxin-treated mice.
Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Endotoxins; Leucine; Leukocytes; Leukopenia; Male; Mice; Mice, Inbred Strains; Shock, Septic | 1991 |